Aaron Seth Rosenberg

Title(s)Associate Professor, MED: Int Med HMCTBMT
SchoolSchool of Medicine
AddressCancer Center
CA 95817
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis. Blood. 2025 Jan 02; 145(1):75-84. Banerjee R, Sexton R, Cowan AJ, Rosenberg AS, Ailawadhi S, Rajkumar SV, Kumar S, Dispenzieri A, Lonial S, Durie BGM, Richardson PG, Usmani SZ, Hoering A, Orlowski RZ. PMID: 39321347.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    2. Clinical characteristics, treatment patterns, and outcomes among African American and White patients with multiple myeloma in the United States. Leuk Lymphoma. 2024 Jan; 65(1):109-117. Saunders A, Slaff S, Subbiah K, Gu T, Ang KK, Quan MA, Rosenberg AS. PMID: 37917858.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    3. Utilization of Autologous Hematopoietic Cell Transplantation Over Time in Multiple Myeloma: A Population-Based Study. Clin Lymphoma Myeloma Leuk. 2024 04; 24(4):e119-e129. Esteghamat NS, Brunson A, Rosenberg AS, Schonfeld SJ, Valcarcel B, Abrahão R, Cooley JJP, Meyer CL, Auletta JJ, Morton LM, Muffly L, Wun T, Keegan THM. PMID: 38195324; PMCID: PMC11624524.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. Predictors of lenalidomide maintenance duration after autologous stem cell transplant in patients with multiple myeloma. J Oncol Pharm Pract. 2023 Oct; 29(7):1715-1724. Rath C, Yoo C, Cheplowitz H, Lo M, Young R, Guglielmo J, Saunders IM, Banerjee R, Young R, Kumar A, Chung A, Rosenberg AS, Costello C, Fine J, Wilson M, Patel N, Banez MT. PMID: 36731514.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. From mechanism to resistance - changes in the use of dexamethasone in the treatment of multiple myeloma. Leuk Lymphoma. 2023 02; 64(2):283-291. Rosenberg AS. PMID: 36308022.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    6. Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehensive cancer center. Leuk Res. 2022 08; 119:106885. Othman T, Moskoff BN, Ho G, Tenold ME, Azenkot T, Krackeler ML, Fisch SC, Potter LA, Kaesberg PR, Welborn JL, Wun T, Esteghamat NS, Hoeg RT, Rosenberg AS, Abedi M, Tuscano JM, Jonas BA. PMID: 35738024.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    7. Allogeneic hematopoietic cell transplantation using non-myeloablative ATG/TLI conditioning for lymphomas. Leuk Lymphoma. 2022 01; 63(1):231-234. Othman T, Moskoff BN, Esteghamat N, Hoeg RT, Rosenberg AS, Jonas BA, Abedi M, Richman C, Tuscano JM. PMID: 34486920.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Outcomes of Adults With Relapsed/Refractory Acute Myeloid Leukemia Treated With Venetoclax Plus Hypomethylating Agents at a Comprehensive Cancer Center. Front Oncol. 2021; 11:649209. Tenold ME, Moskoff BN, Benjamin DJ, Hoeg RT, Rosenberg AS, Abedi M, Tuscano JM, Jonas BA. PMID: 33777810; PMCID: PMC7991747.
      View in: PubMed   Mentions: 26  
    9. Retrospective Analysis of Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia Treated with FLAG at a Comprehensive Cancer Center. Clin Lymphoma Myeloma Leuk. 2021 07; 21(7):e611-e618. Tenold ME, Moskoff BN, Krishnan R, Rosenberg AS, Hoeg RT, Abedi M, Tuscano JM, Jonas BA. PMID: 33811007.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Phase I study of escalating doses of carfilzomib with HyperCVAD in patients with newly diagnosed acute lymphoblastic leukemia. Am J Hematol. 2021 04 01; 96(4):E114-E117. Jonas BA, Fisch SC, Rosenberg AS, Hoeg RT, Tuscano JM, Abedi M. PMID: 33476436.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    11. Effect of autologous hematopoietic stem cell transplant on the development of second primary malignancies in multiple myeloma patients. Blood Cancer J. 2021 01 07; 11(1):5. Rosenberg AS, Brunson A, Tuscano J, Jonas BA, Hoeg R, Wun T, Keegan THM. PMID: 33414400; PMCID: PMC7791054.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    12. Association of Morbid Progression With Overall Survival Among Patients With Multiple Myeloma: Validation of the Progression-free Survival Endpoint. Clin Lymphoma Myeloma Leuk. 2021 05; 21(5):345-354.e4. Rosenberg AS, Facon T, Parikh K, Chung W, Srinivasan S, Kotey S, Tuscano J. PMID: 33563582.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    13. Second primary malignancies in multiple myeloma: A review. Blood Rev. 2021 03; 46:100757. Poh C, Keegan T, Rosenberg AS. PMID: 32972803; PMCID: PMC8282231.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansPHPublic Health
    14. Targeting MCL-1 in hematologic malignancies: Rationale and progress. Blood Rev. 2020 11; 44:100672. Wei AH, Roberts AW, Spencer A, Rosenberg AS, Siegel D, Walter RB, Caenepeel S, Hughes P, McIver Z, Mezzi K, Morrow PK, Stein A. PMID: 32204955; PMCID: PMC7442684.
      View in: PubMed   Mentions: 98     Fields:    Translation:HumansAnimalsCells
    15. Treatment Patterns and Survival in Older Adults with Diffuse Large B-cell Lymphoma: A Population-Based Study. J Registry Manag. 2020; 47(3):135-145. Maguire FB, Li Q, Morris CR, Parikh-Patel A, Rosenberg AS, Keegan THM. PMID: 34128920.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    16. Association Between Autologous Stem Cell Transplant and Survival Among Californians With Multiple Myeloma. J Natl Cancer Inst. 2019 01 01; 111(1):78-85. Rosenberg AS, Brunson A, Jonas BA, Keegan THM, Wun T. PMID: 29897481; PMCID: PMC6335109.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    17. Survival after diffuse large B-cell lymphoma among children, adolescents, and young adults in California, 2001-2014: A population-based study. Pediatr Blood Cancer. 2019 04; 66(4):e27559. Abrahão R, Ribeiro RC, Lichtensztajn DY, Rosenberg AS, Keegan THM. PMID: 30511461; PMCID: PMC9423938.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsCTClinical Trials
    18. Platelet response to direct thrombin inhibitor or fondaparinux treatment in patients with suspected heparin-induced thrombocytopenia. J Thromb Thrombolysis. 2018 May; 45(4):536-542. Pon TK, Mahajan A, Rosenberg A, Amin A, Shah D, Jenkins I, Gupta V, Hofmann H, Bejjani A, White R. PMID: 29574610.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    19. Decreased early mortality associated with the treatment of acute myeloid leukemia at National Cancer Institute-designated cancer centers in California. Cancer. 2018 05 01; 124(9):1938-1945. Ho G, Wun T, Muffly L, Li Q, Brunson A, Rosenberg AS, Jonas BA, Keegan THM. PMID: 29451695; PMCID: PMC6911353.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    20. Assessing the Effect of Adherence on Patient-reported Outcomes and Out of Pocket Costs Among Patients With Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2018 03; 18(3):210-218. Gupta S, Abouzaid S, Liebert R, Parikh K, Ung B, Rosenberg AS. PMID: 29429817.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    21. Impact of latency time on survival for adolescents and young adults with a second primary malignancy. Cancer. 2018 03 15; 124(6):1260-1268. Goldfarb M, Rosenberg AS, Li Q, Keegan THM. PMID: 29205296.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    22. Second Primary Malignant Neoplasms and Survival in Adolescent and Young Adult Cancer Survivors. JAMA Oncol. 2017 Nov 01; 3(11):1554-1557. Keegan THM, Bleyer A, Rosenberg AS, Li Q, Goldfarb M. PMID: 28426850; PMCID: PMC5824209.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    23. Secondary acute lymphoblastic leukemia is a distinct clinical entity with prognostic significance. Blood Cancer J. 2017 09 08; 7(9):e605. Rosenberg AS, Brunson A, Paulus JK, Tuscano J, Wun T, Keegan THM, Jonas BA. PMID: 28885611; PMCID: PMC5709750.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    24. Subsequent primary malignancies after diffuse large B-cell lymphoma in the modern treatment era. Br J Haematol. 2017 07; 178(1):72-80. Tao L, Clarke CA, Rosenberg AS, Advani RH, Jonas BA, Flowers CR, Keegan THM. PMID: 28542862; PMCID: PMC5487277.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    25. Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality. Br J Haematol. 2017 07; 178(2):319-326. Brunson A, Lei A, Rosenberg AS, White RH, Keegan T, Wun T. PMID: 28369826.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    26. Survival Analyses and Prognosis of Plasma-Cell Myeloma and Plasmacytoma-Like Posttransplantation Lymphoproliferative Disorders. Clin Lymphoma Myeloma Leuk. 2016 12; 16(12):684-692.e3. Rosenberg AS, Ruthazer R, Paulus JK, Kent DM, Evens AM, Klein AK. PMID: 27771291; PMCID: PMC5402751.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    27. Investigation into the interference of the monoclonal antibody daratumumab on the free light chain assay. Clin Biochem. 2016 Oct; 49(15):1202-1204. Rosenberg AS, Bainbridge S, Pahwa R, Jialal I. PMID: 27475249.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    28. Hodgkin lymphoma post-transplant lymphoproliferative disorder: A comparative analysis of clinical characteristics, prognosis, and survival. Am J Hematol. 2016 06; 91(6):560-5. Rosenberg AS, Klein AK, Ruthazer R, Evens AM. PMID: 26928381; PMCID: PMC6586231.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    29. Breast cancer and thrombosis: timing matters. Blood. 2016 Feb 18; 127(7):793-4. Paulus JK, Rosenberg AS. PMID: 26893393.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    30. Incidence and evaluation of incidental abnormal bone marrow signal on magnetic resonance imaging. ScientificWorldJournal. 2014; 2014:380814. Shah GL, Rosenberg AS, Jarboe J, Klein A, Cossor F. PMID: 25374938; PMCID: PMC4211153.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    31. Imatinib and prostate cancer: lessons learned from targeting the platelet-derived growth factor receptor. Expert Opin Investig Drugs. 2013 Jun; 22(6):787-94. Rosenberg A, Mathew P. PMID: 23540855.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    Aaron's Networks
    Concepts (146)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (20)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UC Davis Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-12-gbedcc43d on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California